Literature DB >> 22628661

High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda.

Aaron A R Tobian1, Mary K Grabowski, Godfrey Kigozi, Patti E Gravitt, Kevin P Eaton, David Serwadda, Fred Nalugoda, Maria J Wawer, Thomas C Quinn, Ronald H Gray.   

Abstract

OBJECTIVES: Human papillomavirus (HPV) infection causes genital warts, penile cancer and cervical cancer. Africa has one of the highest rates of penile and cervical cancers, but there are little data on high-risk human papillomavirus (HR-HPV) prevalence in heterosexual men. Knowledge of HR-HPV prevalence, risk factors and genotype distribution among heterosexual men is important to establish risk-reduction prevention strategies.
METHODS: 1578 uncircumcised men aged 15-49 years who enrolled in male circumcision trials in Rakai, Uganda, were evaluated for HR-HPV from swabs of the coronal sulcus/glans using Roche HPV Linear Array. Adjusted prevalence risk ratios (adjPRRs) were estimated using modified Poisson multivariable regression.
RESULTS: HPV prevalence (either high risk or low risk) was 90.7% (382/421) among HIV-positive men and 60.9% (596/978) among HIV-negative men (PRR 1.49, 95% CI 1.40 to 1.58). HIV-positive men had a significantly higher risk of infection with three or more HR-HPV genotypes (PRR=5.76, 95% CI 4.27 to 7.79). Among HIV-positive men, high-risk sexual behaviours were not associated with increased HR-HPV prevalence. Among HIV-negative men, HR-HPV prevalence was associated with self-reported genital warts (adjPRR 1.57, 95% CI 1.07 to 2.31). Among all men (both HIV negative and HIV positive), HR-HPV prevalence was associated with more than 10 lifetime sexual partners (adjPRR 1.30, 95% CI 1.01 to 1.66), consistent condom use (adjPRR 1.31, 95% CI 1.08 to 1.60) and HIV infection (adjPRR 1.80, 95% CI 1.60 to 2.02). HR-HPV prevalence was lower among men who reported no sexual partners during the past year (adjPRR 0.47, 95% CI 0.23 to 0.94).
CONCLUSION: The burden of HR-HPV infection is high among heterosexual men in sub-Saharan Africa and most pronounced among the HIV-infected individuals.

Entities:  

Mesh:

Year:  2012        PMID: 22628661      PMCID: PMC3640492          DOI: 10.1136/sextrans-2012-050524

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  30 in total

1.  Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.

Authors:  Anna R Giuliano; Joel M Palefsky; Stephen Goldstone; Edson D Moreira; Mary E Penny; Carlos Aranda; Eftyhia Vardas; Harald Moi; Heiko Jessen; Richard Hillman; Yen-Hwa Chang; Daron Ferris; Danielle Rouleau; Janine Bryan; J Brooke Marshall; Scott Vuocolo; Eliav Barr; David Radley; Richard M Haupt; Dalya Guris
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

2.  Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa.

Authors:  Aaron A R Tobian; Godfrey Kigozi; Patti E Gravitt; Changchang Xiao; David Serwadda; Kevin P Eaton; Xiangrong Kong; Maria J Wawer; Fred Nalugoda; Thomas C Quinn; Ronald H Gray
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

Review 3.  Age-specific prevalence of human papillomavirus infection in males: a global review.

Authors:  Jennifer S Smith; Paul A Gilbert; Amy Melendy; Rashida K Rana; Jeanne M Pimenta
Journal:  J Adolesc Health       Date:  2011-06       Impact factor: 5.012

4.  Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men.

Authors:  Danielle M Backes; Maaike C G Bleeker; Chris J L M Meijer; Michael G Hudgens; Kawango Agot; Robert C Bailey; J O Ndinya-Achola; Juma Hayombe; Cornelis J A Hogewoning; Stephen Moses; Peter J F Snijders; Jennifer S Smith
Journal:  Int J Cancer       Date:  2011-08-02       Impact factor: 7.396

5.  Male human papillomavirus prevalence and association with condom use in Brazil, Mexico, and the United States.

Authors:  Kimberly K Repp; Carrie M Nielson; Rongwei Fu; Sean Schafer; Eduardo Lazcano-Ponce; Jorge Salmerón; Manuel Quiterio; Luisa L Villa; Anna R Giuliano
Journal:  J Infect Dis       Date:  2012-03-06       Impact factor: 5.226

6.  Type-specific human papillomavirus infections among young heterosexual male and female STI clinic attendees.

Authors:  Henrike J Vriend; Hein J Boot; Marianne A B van der Sande
Journal:  Sex Transm Dis       Date:  2012-01       Impact factor: 2.830

7.  Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study.

Authors:  Anna R Giuliano; Ji-Hyun Lee; William Fulp; Luisa L Villa; Eduardo Lazcano; Mary R Papenfuss; Martha Abrahamsen; Jorge Salmeron; Gabriella M Anic; Dana E Rollison; Danelle Smith
Journal:  Lancet       Date:  2011-02-28       Impact factor: 79.321

8.  Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda.

Authors:  Maria J Wawer; Aaron A R Tobian; Godfrey Kigozi; Xiangrong Kong; Patti E Gravitt; David Serwadda; Fred Nalugoda; Frederick Makumbi; Victor Ssempiija; Nelson Sewankambo; Stephen Watya; Kevin P Eaton; Amy E Oliver; Michael Z Chen; Steven J Reynolds; Thomas C Quinn; Ronald H Gray
Journal:  Lancet       Date:  2011-01-06       Impact factor: 79.321

9.  Male circumcision and anatomic sites of penile high-risk human papillomavirus in Rakai, Uganda.

Authors:  Aaron A R Tobian; Xiangrong Kong; Patti E Gravitt; Kevin P Eaton; Godfrey Kigozi; David Serwadda; Amy E Oliver; Fred Nalugoda; Frederick Makumbi; Michael Z Chen; Maria J Wawer; Thomas C Quinn; Ronald H Gray
Journal:  Int J Cancer       Date:  2011-04-01       Impact factor: 7.396

10.  Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain.

Authors:  Anne M Johnson; Catherine H Mercer; Simon Beddows; Natasha de Silva; Sarika Desai; Rebecca Howell-Jones; Caroline Carder; Pam Sonnenberg; Kevin A Fenton; Catherine Lowndes; Kate Soldan
Journal:  Sex Transm Infect       Date:  2012-01-17       Impact factor: 3.519

View more
  6 in total

Review 1.  Translation of biomedical prevention strategies for HIV: prospects and pitfalls.

Authors:  Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

2.  Human papillomavirus prevalence in male and female university students in Gaborone, Botswana.

Authors:  Doreen Ramogola-Masire; Nancy McClung; Anikie Mathoma; Julia W Gargano; Naledi Gape Nyepetsi; Troy D Querec; Juanita Onyekwuluje; Madisa Mine; Chelsea Morroni; Rebecca Luckett; Lauri E Markowitz
Journal:  Epidemiol Infect       Date:  2022-04-06       Impact factor: 4.434

3.  Cervical cancer screening and treatment of cervical intraepithelial neoplasia in female sex workers using "screen and treat" approach.

Authors:  Smita Joshi; Vinay Kulkarni; Trupti Darak; Uma Mahajan; Yogesh Srivastava; Sanjay Gupta; Sumitra Krishnan; Mahesh Mandolkar; Alok Chandra Bharti
Journal:  Int J Womens Health       Date:  2015-05-04

4.  Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis.

Authors:  Cecily Banura; Florence M Mirembe; Jackson Orem; Anthony K Mbonye; Simon Kasasa; Edward K Mbidde
Journal:  Infect Agent Cancer       Date:  2013-07-10       Impact factor: 2.965

5.  Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study.

Authors:  Leiwen Fu; Tian Tian; Kai Yao; Xiang-Feng Chen; Ganfeng Luo; Yanxiao Gao; Yi-Fan Lin; Bingyi Wang; Yinghui Sun; Weiran Zheng; Peiyang Li; Yuewei Zhan; Christopher K Fairley; Andrew Grulich; Huachun Zou
Journal:  JMIR Public Health Surveill       Date:  2022-07-06

6.  Anogenital Human Papillomavirus and HIV Infection in Rwandan Men Who Have Sex With Men.

Authors:  Gad Murenzi; Hae-Young Kim; Athanase Munyaneza; Patrick Tuyisenge; Thierry M Zawadi; Alex M Buteera; Adebola Adedimeji; Leon Mutesa; Philip E Castle; Kathryn Anastos; Joel M Palefsky
Journal:  J Acquir Immune Defic Syndr       Date:  2020-08-15       Impact factor: 3.771

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.